These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
387 related items for PubMed ID: 17225981
1. Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis. Cesana GC, Romano F, Piacentini G, Scotti M, Brenna A, Bovo G, Vaghi M, Aletti G, Caprotti R, Kaufman H, Uggeri F. Ann Surg Oncol; 2007 Apr; 14(4):1295-304. PubMed ID: 17225981 [Abstract] [Full Text] [Related]
2. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients. Romano F, Cesana G, Berselli M, Gaia Piacentini M, Caprotti R, Bovo G, Uggeri F. J Surg Oncol; 2004 Dec 15; 88(4):240-7. PubMed ID: 15565596 [Abstract] [Full Text] [Related]
3. Preoperative IL-2 immunotherapy enhances tumor infiltrating lymphocytes (TILs) in gastric cancer patients. Romano F, Cesana G, Caprotti R, Bovo G, Uggeri F, Piacentini MG, Crippa S, Uggeri F. Hepatogastroenterology; 2006 Dec 15; 53(70):634-8. PubMed ID: 16995478 [Abstract] [Full Text] [Related]
4. Phase-II randomized study of preoperative IL-2 administration in radically operable gastric cancer patients. Romano F, Piacentini MG, Franciosi C, Caprotti R, De Fina S, Cesana G, Uggeri F, Conti M, Uggeri F. Hepatogastroenterology; 2004 Dec 15; 51(60):1872-6. PubMed ID: 15532847 [Abstract] [Full Text] [Related]
5. Radical surgery does not recover immunodeficiency associated with gastric cancer. Romano F, Caprotti R, Bravo AF, Conti M, Colombo G, Piacentini G, Uggeri F, Uggeri F. J Exp Clin Cancer Res; 2003 Jun 15; 22(2):179-83. PubMed ID: 12866567 [Abstract] [Full Text] [Related]
6. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H. Clin Cancer Res; 2003 Oct 01; 9(12):4404-8. PubMed ID: 14555512 [Abstract] [Full Text] [Related]
7. Increased expression of fractalkine is correlated with a better prognosis and an increased number of both CD8+ T cells and natural killer cells in gastric adenocarcinoma. Hyakudomi M, Matsubara T, Hyakudomi R, Yamamoto T, Kinugasa S, Yamanoi A, Maruyama R, Tanaka T. Ann Surg Oncol; 2008 Jun 01; 15(6):1775-82. PubMed ID: 18363071 [Abstract] [Full Text] [Related]
8. Effect of bariatric surgery on peripheral blood lymphocyte subsets in women. Merhi ZO, Durkin HG, Feldman J, Macura J, Rodriguez C, Minkoff H. Surg Obes Relat Dis; 2009 Jun 01; 5(2):165-71. PubMed ID: 18996763 [Abstract] [Full Text] [Related]
9. Characterization of immune responses in gastric cancer patients: a possible impact of H. pylori to polarize a tumor-specific type 1 response? van den Engel NK, Winter H, Rüttinger D, Shau I, Schiller M, Mayer B, Moudgil T, Meimarakis G, Stolte M, Jauch KW, Fox BA, Hatz RA. Clin Immunol; 2006 Sep 01; 120(3):285-96. PubMed ID: 16765089 [Abstract] [Full Text] [Related]
10. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Kawai O, Ishii G, Kubota K, Murata Y, Naito Y, Mizuno T, Aokage K, Saijo N, Nishiwaki Y, Gemma A, Kudoh S, Ochiai A. Cancer; 2008 Sep 15; 113(6):1387-95. PubMed ID: 18671239 [Abstract] [Full Text] [Related]
11. Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Al-Shibli KI, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT. Clin Cancer Res; 2008 Aug 15; 14(16):5220-7. PubMed ID: 18698040 [Abstract] [Full Text] [Related]
12. Search for immunomodulatory effects of blood transfusion in gastric cancer patients: flow cytometry of Th1/Th2 cells in peripheral blood. Sun CF, Hsieh YY, Ngan KW, Wang WT. Ann Clin Lab Sci; 2001 Apr 15; 31(2):171-8. PubMed ID: 11337907 [Abstract] [Full Text] [Related]
13. Impact of tumor-infiltrating T cells on survival in patients with malignant pleural mesothelioma. Anraku M, Cunningham KS, Yun Z, Tsao MS, Zhang L, Keshavjee S, Johnston MR, de Perrot M. J Thorac Cardiovasc Surg; 2008 Apr 15; 135(4):823-9. PubMed ID: 18374762 [Abstract] [Full Text] [Related]
14. [Immunotherapy in radical surgery of colorectal carcinoma]. Brivio F, Fumagalli L, Chiarelli M, Denova M, Bertolini A, Cetta M, Nespoli A. Chir Ital; 2007 Apr 15; 59(5):635-40. PubMed ID: 18019635 [Abstract] [Full Text] [Related]
15. Effect of pre-operative short course famotidine on tumor infiltrating lymphocytes in colorectal cancer: a double blind, placebo controlled, prospective randomized study. Kapoor S, Pal S, Sahni P, Dattagupta S, Kanti Chattopadhyay T. J Surg Res; 2005 Dec 15; 129(2):172-5. PubMed ID: 15882879 [Abstract] [Full Text] [Related]
16. Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor. van Herpen CM, van der Laak JA, de Vries IJ, van Krieken JH, de Wilde PC, Balvers MG, Adema GJ, De Mulder PH. Clin Cancer Res; 2005 Mar 01; 11(5):1899-909. PubMed ID: 15756016 [Abstract] [Full Text] [Related]
17. Phase II randomized study of interleukin-2 with or without 13-cis retinoic acid as maintenance therapy in patients with advanced cancer responsive to chemotherapy. Recchia F, Saggio G, Cesta A, Alesse E, Gallo R, Necozione S, Rea S. Anticancer Res; 2005 Mar 01; 25(4):3149-57. PubMed ID: 16080579 [Abstract] [Full Text] [Related]